002693.SZ
双成药业
SZSE · Healthcare · C 制造业 · CN
CNY 8.90
−5.42%Margins
Gross margin
56.7%
EBITDA margin
22.2%
EBIT margin
7.6%
Net margin
11.3%
FCF margin
13.6%
7.8%
Return on equity
4.0%
Return on assets
4.4%
Return on invested capital
0.35x
Asset turnover
CNY 86.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026